Literature DB >> 3772783

Corneal opacities secondary to Viscoat.

S Ullman, S B Lichtenstein, K Heerlein.   

Abstract

Viscoat is a new viscoelastic solution of chondroitin sulfate and sodium hyaluronate dissolved in a phosphate buffer. Recent findings of postoperative corneal deposits in association with its use have been reported to Cilco. The corneal deposits are noted 18 to 48 hours postoperatively and are similar in appearance to calcific band keratopathy. The clinical characteristics and prognosis of this entity are reviewed. Possible methods of treatment and recommendations for prevention are discussed.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3772783     DOI： 10.1016/s0886-3350(86)80121-3

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN： 0886-3350            Impact factor:   3.351


  5 in total

1.  Investigation and management of an epidemic of Hydroview intraocular lens opacification.

Authors:  R W Altaie; T Costigan; S Donegan; P O'brien; U Mahmood; A J Bogdan; S Beatty
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-11       Impact factor: 3.117

2.  Viscoelastic-Induced Interlamellar Stromal Keratopathy (VISK) during Cataract Surgery in a Patient with a History of Laser in situ Keratomileusis.

Authors:  Matthew Chang; Rosalind C Vo; Stewart Bernard; Stephanie Hoatson; Julio Narvaez
Journal:  Case Rep Ophthalmol       Date:  2022-03-17

3.  Unusual deposits in the superficial corneal stroma following combined use of topical corticosteroid and beta-blocking medication.

Authors:  W M Huige; W H Beekhuis; W J Rijneveld; N Schrage; L Remeijer
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

4.  Penetrating keratoplasty in children under 3 years old with congenital corneal opacities.

Authors:  Made Susiyanti; Burhana Mawarasti; Florence M Manurung
Journal:  Int J Ophthalmol       Date:  2022-01-18       Impact factor: 1.779

5.  Intraocular Lens Opacification following Intracameral Injection of Recombinant Tissue Plasminogen Activator to Treat Inflammatory Membranes after Cataract Surgery.

Authors:  Simon S M Fung; Evripidis Sykakis; Niaz M Islam; Hadi J Zambarakji; Ramin Khoramnia; Gerd U Auffarth; Dipak N Parmar
Journal:  J Ophthalmol       Date:  2015-03-18       Impact factor: 1.909
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.